Pharma & Biotech

Eli Lilly is making an unprecedented $6.5 billion wager on a single facility in Texas, dedicated to a drug that...

ImmunityBio is capturing significant attention with a series of clinical successes that are reshaping its investment profile. The biotech firm...

A wave of positive analyst sentiment is bolstering the outlook for Assembly Biosciences, with Citizens JMP initiating coverage on the...

The telehealth sector faces renewed scrutiny as Hims & Hers Health finds itself in the crosshairs of US regulators. A...

KalVista Pharmaceuticals finds itself navigating conflicting market currents following the announcement of a significant capital raise. The biotech firm secured...

A remarkable case study from Germany, demonstrating a successful treatment for a severe form of ulcerative colitis, is fueling a...

Shares of gene-editing specialist Intellia Therapeutics have experienced significant momentum, driven by a major late-stage clinical development achievement. Investor enthusiasm...

As the patent protection for its blockbuster drug Jakafi approaches expiration, biopharmaceutical firm Incyte is implementing a two-pronged strategy to...

Shares of Viking Therapeutics experienced a notable upswing this week, climbing 7.4% on Wednesday to close at $26.82. The catalyst...

In a trading session characterized by broad market weakness, Mirati Therapeutics shares demonstrated exceptional resilience. The stock held completely flat,...